Post-market Clinical Trial of the Dominus® Stent-Graft

NCT06270537 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-08-22

No results posted yet for this study

Summary

Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use

Conditions

  • Thoracic Aortic Dissection

Interventions

DEVICE

Stent-Graft Dominus® Endoprosthesis

Placement of the Dominus® Stent-Graft for endovascular repair of diseases of the Thoracic Aorta

Sponsors & Collaborators

  • Braile Biomedica Ind. Com. e Repr. Ltda.

    lead INDUSTRY

Principal Investigators

  • Edwaldo Joviliano · Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-24
Primary Completion
2025-07-30
Completion
2029-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06270537 on ClinicalTrials.gov